Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, volume 25, issue 2, pages 70-77
Drug-Induced Movement Disorders
Amy Lustig
1
,
Cesar Ruiz
2
1
Private Speech Pathology Practice, Restorative Speech & Swallow, LLCJenkintown, PA
|
Publication type: Journal Article
Publication date: 2015-04-01
SJR: —
CiteScore: —
Impact factor: —
ISSN: 19407769, 19407777
General Medicine
Abstract
The purpose of this article is to present a general overview of the features of drug-induced movement disorders (DIMDs) comprised by Parkinsonism and extrapyramidal symptoms. Speech-language pathologists (SLPs) who work with patients presenting with these issues must have a broad understanding of the underlying disease process. This article will provide a brief introduction to the neuropathophysiology of DIMDs, a discussion of the associated symptomatology, the pharmacology implicated in causing DIMDs, and the medical management approaches currently in use.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.